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Neonatal sepsis is a critical condition caused by a generalized bacterial infection in the first month of 
life. The present study aimed to investigate the relationship between serum vitamin D levels and 
neonatal sepsis. 
Materials and Methods: A search of online databases (Medline, Cochrane Library, Web of Science, 
EMBASE-Ovid, and Scopus) were carried out for randomized control trials and non-randomized 
prospective or retrospective clinical studies published in English till April 2020. Two reviewers 
selected the studies. 
Results: In the first study, the level of 25-hydroxyvitamin D [25(OH)D] in the cord-blood sample of 
infants in the Early-Onset Neonatal Sepsis (EONS) group was significantly lower compared to the 
control group. 25(OH)D level (19 ng/ml) in the control group were significantly higher compared to 
the 25(OH) level (8.6 ng/ml) in the sepsis group. In the third study, the serum 25(OH) level showed a 
significant decrease in the affected neonates (6.4 nmol/L) compared to healthy neonates (42.5 
nmol/L). In the fourth study, the sepsis and control group had a significant difference in the level of 
25(OH)D (69±7.5ng/ml and 35±19ng/ml). According to the fifth study, the serum 25(OH)D level was 
insufficient in the case group and sufficient in the control group (p<0.0001). In the sixth study, the 
odds of very-early-onset neonatal sepsis among the neonates who had the serum 25-hydroxyvitamin D 
deficiency were lower compared to the odds among neonates who did not have serum 25-
hydroxyvitamin D deficiency. 
Conclusion 
The level of 25-hydroxyvitamin D in the blood sample of infants in the sepsis group was significantly 
lower compared to the control group; further studies required to confirm the results by considering 
more confounders. 
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1- INTRODUCTION 
      Neonatal sepsis is a risk that includes 
over 40% of neonatal mortality, with more 
than 3 million neonate deaths annually 
worldwide (1). The prevalence of the 
disease has been reported 1-8 cases out of 
1000 live births (2). The term neonatal 
septicemia is earmarked to conditions of 
bacterial, viral, and fungal infections that 
exhibit hemodynamic changes, as well as 
other clinical manifestations, and 
accompanies considerable somatic injuries 
and mortality potential. Despite the 
experience of caring for the suspected 
neonates or its definite diagnosis for 
several years, there are still challenges of 
the consensus in describing neonatal sepsis 
(3). The clinical diagnosis of the disease is 
difficult due to its nonspecific symptoms 
and manifestations, and neonate specialists 
confront challenges in diagnosing and 
managing neonatal sepsis contrary to the 
presence of laboratory tests (4).  
Although the survival probability of the 
infected neonates has enhanced as a result 
of treatments using the antibiotic regimens, 
dissatisfaction with its therapeutic 
management persists (5). Although the 
symptoms of neonatal sepsis have been 
identified for a long time, researchers have 
not yet attained any convincing success 
(6). Early neonatal sepsis includes the 
emergence of symptoms during 72 hours 
after birth and mainly results from the 
group B streptococcus that manifests 
during delivery and as a result of vertical 
mother-to-fetus transmission. The later 
version emerges from the 3rd-7th day after 
birth owing to environmental contacts with 
the hospital and the atmosphere of the 
outdoors. A premature birth (before the 
due date), and an increase in 
hospitalization time are of the factors, 
which raise the potential risk of sepsis. 
However, some cases of late neonatal 
sepsis have been reported in the first week 
to the third month after birth (7). The 
sepsis-suspicious neonates are examined 
using the symptoms of skin colour, 
Hypotonia, Bradycardia, Apnea, 
respiratory distress, liver enlargement, 
digestive symptoms, outnumbered 
leukocytes, Thrombocytopenia, and 
metabolic acidosis (8). Consideration of 
predisposing factors such as 
hospitalization in an intensive care nursery 
and the weakness of the immune system, 
especially in premature neonates, along 
with maternal factors such as the long-term 
rupture of the embryonic membrane, 
unpleasant smell rising from the amniotic 
fluid during delivery, low-weight, and 
neonatal anomalies is crucial in diagnosing 
and managing this disease since they 
increase the risk of septicemia (9, 10).  
Besides, different studies have addressed 
the low level of 25-hydroxyvitamin D, 
which is related to aborning low weight, 
pregnancy age, and even aborning Apgar 
score (10).  The results of studies have 
referred to the direct relationship between 
vitamin D deficiency, as a potential risk 
factor in the weakness of the immune 
system, and the heightened probability of 
sepsis pathogenesis. In this respect, the 
association between deficiency at the 
average vitamin D level of mothers and the 
possibility of early neonatal sepsis has 
been posed (11). According to the results 
of some studies, the25-hydroxyvitamin D 
level deficiency in the cord blood is linked 
to the emergence of sepsis in the first year 
after birth (12).  
Since neonatal sepsis still imposes a heavy 
burden on the health system even after 
many years, perceiving the disease phases 
and controlling them are of utmost 
importance. In this regard, it is essential to 
accurately measure the vitamin D serum 
level of mothers based on the instructions 
of the health system. Besides, scientific 
evidence has shown noticeable variations 
in conditions such as inflammation and 
stress perception during the assessment of 
the 25-hydroxyvitamin D levels of 
pregnant mothers. Thus, more precise 
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measurement and further studies are 
recommended (13) so that the preventive 
and therapeutic role of vitamin D in the 
manifestation and pursuance of neonatal 
sepsis is clarified (6). The present study 
aimed to review the studies conducted on 
determining the mothers' and neonates' 
vitamin D serum levels, which are 
associated with neonatal sepsis.  
2- MATERIALS AND METHODS 
2-1. Information sources 
      Following electronic databases were 
search to find the Relation between Sepsis 
and Vitamin D Level among neonatal 
intensive care unit infants: Medline (via 
PubMed), Cochrane library, EMBASE-
Ovid, Web of Science and Scopus for 
randomized control trial and non-
randomized prospective or retrospective 
clinical studies. The studies published in 
English to April 2020. The search was 
carried out independently in duplication by 
two reviewers, and the supervisor 
dissolved any disagreement between the 
reviews. 
2-2. Search 
Keywords were a combination of: 
"Neonatal sepsis/ Sepsis/" AND 
"Ergocalciferols OR Vitamin D" AND 
"Infant/Neonate".  
2-3. Study selection 
A database search was carried out for 
possible studies. Moreover, the abstracts of 
the studies were screened for identification 
of eligible studies and the full-text articles 
were obtained, assessed, and a final list of 
included studies was made. This process 
was carried out independently and in 
duplication by two reviewers, and the third 
reviewer resolved any disagreement.  
3- RESULTS 
      Finally six studies were included in 
this systematic review. According to the 
18-month study by Cizmeci et al., the 
number of NICU infants with suspected 
Early-Onset Neonatal Sepsis (EONS) was 
53 out of 2,571 live births. The level of 
25(OH)D in the cord-blood sample of 
infants in the study group 12.6 ng/mL (3.1 
to 78.9) was significantly lower compared 
to the control group (median 21 ng/mL (5 
to 118) (p=0.038). The multivariate 
models showed a relationship between 
high risk of EONS and low cord-blood 
25(OH)D level of <30 ng/ml (OR: 5.6; 
95 % CI: 1.3–23.5) (13).  
Cizmeci et al. reported that neonatal 25-
OHD levels (19 ng/ml) in the control 
group were significantly higher compared 
to the sepsis group. There was a direct 
correlation between neonatal and maternal 
25-OHD levels. The sepsis group exhibited 
significantly severe vitamin D deficiency 
(14). In a study conducted by Gamal et al., 
50 neonates with early-onset sepsis (25 
full-term and 25 preterm infants), and 30 
age and sex-matched healthy neonates as 
controls were included. The mean 
gestational age was 34.1 ± 1.26 for 
preterm neonates with sepsis and 37.5 ± 
0.98 for full-term with sepsis. The serum 
25-OH D level was significantly lower in 
the infected neonates (6.4 ± 1.8 and 24.6 + 
2.2 nmol/L) compared to healthy neonates 
(42.5 ± 20.7 and 50.4+ 21.4  nmol/L).  
There were significant negative 
correlations between neonatal and 
maternal 25-OH vitamin D serum levels 
and all sepsis markers. Moreover, there 
were significant positive correlations 
between neonatal and maternal 25-OH 
vitamin D levels (11). Çekmez et al. 
included 106 term babies consisted of 20 
controls in their study. Newborn blood 
samples were collected from the first day 
of sepsis. The patients with sepsis and 
controls showed a significant difference in 
the level of 25(OH)D (69±7.5 ng/ml and 
35±19 ng/ml, p=0.0l) (6). In Das et al.'s 
study, the serum 25(OH)D was assessed, 
the primary circulating form of vitamin D 
on 120 subjects in a case-control approach, 
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recruiting 60 subjects in each category. 
The serum 25(OH)D level was insufficient 
(median = 12.16 ng/ml, 95% CI: 3.84–
22.22) in the case group, and sufficient in 
the control group (median = 30.22 ng/ml, 
95% CI: 20.08–46.78; p=0.0001), 
highlighting the higher prevalence of 
vitamin D deficiency in case group (15). 
Oleo et al. conducted a case-control study 
on maternal serum 25(OH)D levels and the 
risk of very early-onset neonatal sepsis. 
The odds of very-early-onset neonatal 
sepsis among the neonates who were 
serum 25(OH)D deficient was lower 
compared to the odds among neonates who 
were not serum 25(OH)D deficient (OR: -
0.40, 95% CI: 0.13-1.15, p=0.059) (16). 
4- DISCUSSION 
     This study aimed to investigate the 
relationship between serum vitamin D 
levels and neonatal sepsis. Six studies 
were included into the systematic review. 
The level of 25-hydroxyvitamin D in the 
sepsis group was significantly lower 
compared to control groups. There was a 
direct correlation between neonatal and 
maternal 25-OHD levels. Although 
deficiency at the average level of vitamin 
D of mothers is a global issue stemming 
from inappropriate regimens, skin 
coverage, and insufficient exposure to 
sunlight, therefore the utilization of the 25-
hydroxyvitamin D supplement during 
pregnancy seems necessary if needed (11).  
The role of vitamin D deficiency and its 
direct association with the pathogenesis 
power of infections in other diseases have 
been also posited (17). Various studies has 
revealed that vitamin D and its metabolites 
are related to several illnesses, including 
cancer, diabetes, asthma, and sepsis. Since 
the innate immune systems of neonates are 
not fully developed, they are more 
susceptible to be afflicted by various 
infections. Hence, the exposure of 
neonates to sunlight as a conventional 
method justifies this problem that it can 
fortify the neonate's immune system and 
protect them from other infections (15). 
Concerning the early sensitivity of 
neonates to vitamin D deficiency in this 
period, it may also play the significant role 
in the growth of uterine lungs. It seems 
that vitamin D deficiency noticeably 
reduces lung volume. Moreover, vitamin D 
deficiency disposes neonates to respiratory 
infections by reducing their breathing 
storage (18). However, the neonates whose 
vitamin D level of their cord blood has 
been reported normal less suffer from 
acute respiratory infection (19).  
The neonates of the mothers with vitamin 
D deficiency at their pregnancy show more 
stertor rate and are at risk of severe 
respiratory diseases in the first three 
months of their lives (18). The effect of the 
serum level adequacy of vitamin D 
associates with the decreased risk of the 
vertical transmission of infection from 
mothers suffering from HIV to fetuses 
(19). Recent studies have proved the 
importance of vitamin D besides antibiotic 
regimens on increasing the survival chance 
of infants with acute and chronic diseases.  
The immediate reception of vitamin D 
supplements, and consequently, fortifying 
their immune system against infections, 
protects susceptible neonates from the 
emergence of early and late neonatal sepsis 
(15). Of course, the serum level adequacy 
of 25-hydroxyvitamin D of mothers is 
important in the first three months of 
pregnancy in supplying fetus storage and 
reinforcing their immune system. This 
issue is specifically noticed in neonates 
that are born before the 32nd week of 
pregnancy (11). Nevertheless, deficiency 
in the vitamin D storage of mothers in 
European countries, Canada, and Middle 
East countries is a global problem, and 
two-third of young and healthy women 
suffer from its storage deficiency (20). The 
risk of affliction by acute respiratory 
infection is higher among neonates 
suffering from vitamin D deficiency, and 
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this sequel is the common reason for 
neonatal mortality, particularly in 
developing countries (18). However, the 
effect of vitamin D on the immune system 
has not been well documented; there is 
dispersed evidence on its effect on 
neonatal consequences (13). Likewise, the 
most suitable dose and consumption time 
of vitamin D by mothers in their 
pregnancy period for the conservation of 
sufficient rates in mothers and neonates are 
not specified. Nevertheless, supervising 
the agreement of mothers with vitamin D 
supplements and personalizing the rate of 
vitamin D supplement based on the 
measured vitamin D improve vitamin D 
level in neonates. Some caution 
concerning the importance of proper 
nutrition, vitamin D supplement, and 
exposition to the sunlight should be given 
to mothers in their pregnancy period (18). 
Longitudinal studies are required to 
confirm our results and develop 
mechanisms between the 25-
hydroxyvitamin D and ALRTI serum 
levels in neonates contriving these 
observations.       
5- CONCLUSION 
      The level of 25-hydroxyvitamin D in 
the blood sample of infants in with sepsis 
group was significantly lower compared to 
the control group. There was a direct 
correlation between neonatal and maternal 
25-OHD levels. Further studies are 
required to confirm the results by 
considering more confounders. 
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